Popovits Kimberly J — SEC Form 4 filings
SEC reporting owner CIK 1333482. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-06-07 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Director | 4 | — | — | 17 |
| EXACT SCIENCES CORP (EXAS) | Director | 3 | — | — | 4 |
| 10x Genomics, Inc. (TXG) | Director | 3 | — | — | 3 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Director | 1 | — | — | 2 |
| Kardigan, Inc. (KARD) | Director | 1 | — | — | 1 |
Form 4 filings — Popovits Kimberly J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | Kardigan, Inc. (KARD) | Grant/award (A): 20,706 @ $0 | EDGAR |
| 2026-06-08 | 4 | 10x Genomics, Inc. (TXG) | Grant/award (A): 8,829 @ $0 | EDGAR |
| 2026-06-02 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,799 · Grant/award (A): 12,158 (derivative) @ $0 · Grant/award (A): 2,026 (derivative) @ $0 · Option exercise (M): 2,799 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 6,808 (derivative) @ $0 · Grant/award (A): 10,257 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | EXACT SCIENCES CORP (EXAS) | Disposition to issuer (D): 6,725 · Disposition to issuer (D): 9,656 | EDGAR |
| 2025-08-01 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 45,748 @ $10.36 · Option exercise (M): 18,760 @ $15.47 · Option exercise (M): 64,508 @ $29.90 · Option exercise (M): 45,748 (derivative) @ $0 · Option exercise (M): 18,760 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 9,994 @ $0 | EDGAR |
| 2025-06-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 3,173 · Grant/award (A): 16,798 (derivative) @ $0 · Grant/award (A): 2,799 (derivative) @ $0 · Option exercise (M): 3,173 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | 10x Genomics, Inc. (TXG) | Grant/award (A): 15,357 @ $0 | EDGAR |
| 2025-01-06 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 6,387 @ $0 | EDGAR |
| 2024-06-13 | 4 | 10x Genomics, Inc. (TXG) | Grant/award (A): 8,649 @ $0 | EDGAR |
| 2024-06-07 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 4,373 · Grant/award (A): 19,040 (derivative) @ $0 · Grant/award (A): 3,173 (derivative) @ $0 · Option exercise (M): 4,373 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1333482 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →